• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清和脑脊液神经丝轻链水平在获得性周围神经病患者中的变化。

Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies.

机构信息

Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

出版信息

J Peripher Nerv Syst. 2018 Sep;23(3):174-177. doi: 10.1111/jns.12279. Epub 2018 Jul 24.

DOI:10.1111/jns.12279
PMID:29974556
Abstract

Neurofilament light chain (NFL) levels reflect axonal damage in different inflammatory and neurodegenerative central nervous system conditions, in correlation with disease severity. Our aim was to determine the possible diagnostic and prognostic value of serum and cerebrospinal fluid (CSF) NFL levels in subjects with different forms of acquired peripheral neuropathies (PN). Paired serum and CSF samples of 25 patients with acquired PN were analysed for NFL using an ultrasensitive technique (Quanterix, Simoa, Lexington, MA, USA) and compared with a group of 25 age-matched healthy subjects. Demographic, clinical, CSF and neurophysiological data were reviewed. Cases with Guillain-Barré syndrome (N = 5), multifocal motor neuropathy (N = 3), chronic inflammatory demyelinating polyneuropathy (CIDP) and variants (N = 12), anti-myelin-associated glycoprotein (MAG) neuropathy (N = 3), both CIDP and anti-MAG neuropathy (N = 1), and non-systemic vasculitic neuropathy (N = 1) were studied. NFL levels were significantly (P < 0.001) increased in patients with PN and were higher in the CSF (median: 1407 pg/mL, range: 140.2-12 661) than in serum (median: 31.52 pg/mL, range: 4.33-1178). A statistically significant correlation was observed between serum and CSF levels in cases with blood-nerve-barrier damage (r = 0.71, P < 0.01), and between serum NFL levels and disease activity at sampling (r = 0.52, P < 0.01) and at last follow-up (r = 0.53, P < 0.01) in all subjects. The increase of NFL values in both serum and CSF of patients with acquired PN and the significant correlation between serum NFL levels, disease severity and final outcome support the possible role of NFL as disease activity and prognostic biomarker also in peripheral nervous system disorders.

摘要

神经丝轻链(NFL)水平反映了不同炎症性和神经退行性中枢神经系统疾病中的轴突损伤,与疾病严重程度相关。我们的目的是确定血清和脑脊液(CSF)NFL 水平在不同获得性周围神经病(PN)患者中的可能诊断和预后价值。使用超灵敏技术(Quanterix,Simoa,马萨诸塞州列克星敦)分析 25 例获得性 PN 患者的配对血清和 CSF NFL 样本,并与 25 名年龄匹配的健康对照者进行比较。回顾了人口统计学、临床、CSF 和神经生理学数据。研究了格林-巴利综合征(N = 5)、多灶性运动神经病(N = 3)、慢性炎症性脱髓鞘性多发性神经病(CIDP)及其变体(N = 12)、抗髓鞘相关糖蛋白(MAG)神经病(N = 3)、CIDP 和抗 MAG 神经病(N = 1)以及非系统性血管炎性神经病(N = 1)的病例。PN 患者的 NFL 水平显著升高(P < 0.001),且在 CSF 中(中位数:1407 pg/mL,范围:140.2-12661)高于血清(中位数:31.52 pg/mL,范围:4.33-1178)。在有血液-神经屏障损伤的病例中观察到血清和 CSF 水平之间存在统计学显著相关性(r = 0.71,P < 0.01),并且在所有患者中,血清 NFL 水平与采样时的疾病活动度(r = 0.52,P < 0.01)和最后随访时(r = 0.53,P < 0.01)之间存在显著相关性。获得性 PN 患者血清和 CSF 中 NFL 值的升高以及血清 NFL 水平与疾病严重程度和最终结局之间的显著相关性支持 NFL 作为疾病活动度和预后生物标志物在周围神经系统疾病中的可能作用。

相似文献

1
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies.血清和脑脊液神经丝轻链水平在获得性周围神经病患者中的变化。
J Peripher Nerv Syst. 2018 Sep;23(3):174-177. doi: 10.1111/jns.12279. Epub 2018 Jul 24.
2
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.抗抗体介导性脑炎患者的血清和脑脊液神经丝轻链水平。
J Neurol. 2019 Jul;266(7):1643-1648. doi: 10.1007/s00415-019-09306-z. Epub 2019 Apr 3.
3
Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies.神经丝轻链和总 tau 在急性和慢性炎症性多神经病的鉴别诊断和预后评估中的作用。
Eur J Neurol. 2022 Sep;29(9):2810-2822. doi: 10.1111/ene.15428. Epub 2022 Jun 20.
4
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.一种新的脑脊液神经丝轻链酶联免疫吸附测定法:分析验证和临床评估。
Alzheimers Res Ther. 2018 Jan 23;10(1):8. doi: 10.1186/s13195-018-0339-1.
5
Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.血清神经丝轻链水平在抗 NMDA 受体脑炎中的预测价值。
Neurology. 2023 May 23;100(21):e2204-e2213. doi: 10.1212/WNL.0000000000207221. Epub 2023 Apr 4.
6
Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.中枢神经系统炎性脱髓鞘疾病患者脑脊液神经丝轻链增加。
Mult Scler Relat Disord. 2019 May;30:123-128. doi: 10.1016/j.msard.2019.02.009. Epub 2019 Feb 8.
7
Ratio and index of Neurofilament light chain indicate its origin in Guillain-Barré Syndrome.神经丝轻链的比值和指数表明其起源于吉兰-巴雷综合征。
Ann Clin Transl Neurol. 2020 Nov;7(11):2213-2220. doi: 10.1002/acn3.51207. Epub 2020 Oct 8.
8
Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy.血清神经丝轻链、接触蛋白-1 和补体激活与抗 MAG IgM 副蛋白相关性周围神经病有关。
J Neurol. 2022 Jul;269(7):3700-3705. doi: 10.1007/s00415-022-10993-4. Epub 2022 Feb 14.
9
Peripherin is a biomarker of axonal damage in peripheral nervous system disease.外周蛋白是周围神经系统疾病轴突损伤的生物标志物。
Brain. 2023 Nov 2;146(11):4562-4573. doi: 10.1093/brain/awad234.
10
Association of serum neurofilament light chain levels with clinicopathology of chronic inflammatory demyelinating polyneuropathy, including NF155 reactive patients.血清神经丝轻链水平与慢性炎症性脱髓鞘性多发性神经病的临床病理的相关性,包括 NF155 反应性患者。
J Neurol. 2021 Oct;268(10):3835-3844. doi: 10.1007/s00415-021-10537-2. Epub 2021 Apr 2.

引用本文的文献

1
Mapping the neuropathic pain biomarker landscape (2004-2024): A bibliometric analysis of thematic evolution, research silos, and the translational gap.绘制神经性疼痛生物标志物全景图(2004 - 2024年):主题演变、研究孤岛及转化差距的文献计量分析
Medicine (Baltimore). 2025 Sep 5;104(36):e44265. doi: 10.1097/MD.0000000000044265.
2
Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases.血清和脑脊液中的神经丝轻链参考值:神经疾病的双室分析
J Neurol. 2025 Jul 25;272(8):535. doi: 10.1007/s00415-025-13271-1.
3
Cerebrospinal fluid biomarkers of efficacy in patients affected by spinal muscular atrophy type 1 treated with nusinersen.
接受诺西那生治疗的1型脊髓性肌萎缩症患者疗效的脑脊液生物标志物
Acta Neurol Belg. 2025 May 3. doi: 10.1007/s13760-025-02784-1.
4
Cardiovascular Health and Biomarkers of Neurodegenerative Disease in Older Adults.老年人的心血管健康与神经退行性疾病生物标志物
JAMA Netw Open. 2025 Mar 3;8(3):e250527. doi: 10.1001/jamanetworkopen.2025.0527.
5
Evaluation of the Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantations in ALS Patients by Investigating Patients' Specific Immunological and Biochemical Biomarkers.通过研究患者特定的免疫和生化生物标志物评估间充质干细胞重复移植在肌萎缩侧索硬化症患者中的安全性和有效性。
Diseases. 2024 May 12;12(5):99. doi: 10.3390/diseases12050099.
6
Biomarkers of Neurodegeneration and Alzheimer's Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study.青少年和青年期发病的1型或2型糖尿病患者神经退行性变和阿尔茨海默病神经病理学的生物标志物:一项概念验证研究。
Endocrines. 2024 Jun;5(2):197-213. doi: 10.3390/endocrines5020014. Epub 2024 May 6.
7
Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy.神经丝在鉴别运动神经元病与多灶性运动神经病中的诊断价值。
J Neurol. 2024 Jul;271(7):4441-4452. doi: 10.1007/s00415-024-12355-8. Epub 2024 Apr 29.
8
Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment.血清神经丝轻链和炎症细胞因子作为轻度认知障碍早期检测的生物标志物。
Sci Rep. 2024 Apr 20;14(1):9072. doi: 10.1038/s41598-024-59530-5.
9
Neurofilaments as biomarkers in neurological disorders - towards clinical application.神经丝作为神经紊乱的生物标志物——迈向临床应用。
Nat Rev Neurol. 2024 May;20(5):269-287. doi: 10.1038/s41582-024-00955-x. Epub 2024 Apr 12.
10
Biomarkers and signaling pathways of diabetic nephropathy and peripheral neuropathy: possible therapeutic intervention of rutin and quercetin.糖尿病肾病和周围神经病变的生物标志物及信号通路:芦丁和槲皮素可能的治疗干预
Diabetol Int. 2023 Dec 19;15(2):145-169. doi: 10.1007/s13340-023-00680-8. eCollection 2024 Apr.